| Date | Time | Source | Headline | Symbol | Company |
| 04/20/2017 | 6:04AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/13/2017 | 4:37PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/06/2017 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/02/2017 | 3:57PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/02/2017 | 3:55PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/02/2017 | 3:51PM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/02/2017 | 11:32AM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 4:56PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 4:50PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 3:36PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:30PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:24PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:19PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:17PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 12:13PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 9:52AM | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 9:41AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 8:45AM | PR Newswire (US) | Lilly Completes Acquisition of CoLucid Pharmaceuticals | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 6:31AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 03/01/2017 | 6:18AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/14/2017 | 12:33PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/14/2017 | 11:58AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/14/2017 | 11:15AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/10/2017 | 4:32PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |
| 02/10/2017 | 3:39PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:CLCD | Colucid Pharmaceuticals, Inc. |